📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Shasqi

1.1 - Company Overview

Shasqi Logo

Shasqi

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of a click chemistry-based technology platform (CAPAC) that activates cancer drugs at the tumor site to minimize toxicity and improve outcomes; developer of SQ3370, a clinically validated asset that activates a doxorubicin protodrug with demonstrated safety and efficacy in advanced soft tissue sarcoma; offers antigen-targeting activators and protodrugs for payloads like monoclonal antibodies and traditional chemotherapy agents; in research collaboration with Johnson & Johnson.

Products and services

  • CAPAC: A click-chemistry-based platform that activates cancer drugs directly at the tumor site, aiming to minimize toxicity and improve therapeutic outcomes via in-human activation
  • Antigen-targeting Activators and Protodrugs: Antigen-targeted components deployed within CAPAC to target and activate cancer drugs at the tumor site using payloads like monoclonal antibodies and traditional chemotherapy agents
  • SQ3370: A clinically validated asset that activates a doxorubicin protodrug at the tumor, demonstrating safety and efficacy in patients with advanced soft tissue sarcoma

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Shasqi

NovelStem Logo

NovelStem

HQ: United States Website
  • Description: Provider of diagnostic technology and biotech solutions, including NewStem Diagnostic for early detection of anti-cancer drug resistance aiding targeted cancer treatments, NewStem Therapeutics using proprietary HhESCs for drug and gene screenings to identify genes and drugs for genetic and epigenetic disorders, NewStem Cell Growth Media to improve hPSC growth, and Net Force, a publishing franchise on digital crime, espionage, and crypto.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full NovelStem company profile →
Pharmacyclics Logo

Pharmacyclics

HQ: United States Website
  • Description: Provider of clinical-stage biopharmaceutical research and development focused on discovering and developing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Pharmacyclics company profile →
AltruBio Logo

AltruBio

HQ: United States Website
  • Description: Provider of targeted antibody therapeutics for cancer and immune related inflammatory diseases, including ALTB-168, a humanized antibody targeting late-stage, chronically activated T cells with clinical efficacy in psoriasis, psoriatic arthritis, ulcerative colitis, and acute graft versus host disease, and ALTB-268, a second-generation antibody in trials for ulcerative colitis and psoriatic arthritis.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full AltruBio company profile →
Origo Biopharma Logo

Origo Biopharma

HQ: Spain Website
  • Description: Provider of research and development of immunotherapeutic products targeting health disorders related to TGF-beta signaling dysfunction, including cancer and fibrosis.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Origo Biopharma company profile →
Theriva Biologics Logo

Theriva Biologics

HQ: United States Website
  • Description: Provider of biologics for the prevention and treatment of serious infectious diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Theriva Biologics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Shasqi

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Shasqi

2.2 - Growth funds investing in similar companies to Shasqi

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Shasqi

4.2 - Public trading comparable groups for Shasqi

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Shasqi

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Shasqi

What does Shasqi do?

Shasqi is a provider of a click chemistry-based technology platform (CAPAC) that activates cancer drugs at the tumor site to minimize toxicity and improve outcomes; developer of SQ3370, a clinically validated asset that activates a doxorubicin protodrug with demonstrated safety and efficacy in advanced soft tissue sarcoma; offers antigen-targeting activators and protodrugs for payloads like monoclonal antibodies and traditional chemotherapy agents; in research collaboration with Johnson & Johnson.

Who are Shasqi's competitors?

Shasqi's competitors and similar companies include NovelStem, Pharmacyclics, AltruBio, Origo Biopharma, and Theriva Biologics.

Where is Shasqi headquartered?

Shasqi is headquartered in United States.

How many employees does Shasqi have?

Shasqi has 1,000 employees 🔒.

When was Shasqi founded?

Shasqi was founded in 2010 🔒.

What sector and industry vertical is Shasqi in?

Shasqi is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Shasqi

Who are the top strategic acquirers in Shasqi's sector and industry

Top strategic M&A buyers and acquirers in Shasqi's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Shasqi?

Top strategic M&A buyers groups and sectors for Shasqi include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Shasqi's sector and industry vertical

Which are the top PE firms investing in Shasqi's sector and industry vertical?

Top PE firms investing in Shasqi's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Shasqi's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Shasqi's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Shasqi's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Shasqi include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Shasqi's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Shasqi?

The key public trading comparables and valuation benchmarks for Shasqi include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Shasqi for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Shasqi with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Shasqi's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Shasqi with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Shasqi's' sector and industry vertical?

Access recent funding rounds and capital raises in Shasqi's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Shasqi

Launch login modal Launch register modal